Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial

BACKGROUND: Differences in serotonergic neurotransmission could lead to sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitors (SSRIs). AIMS: We investigated whether women have greater reductions in depressive symptoms than men after trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gougoulaki, Marilia, Lewis, Glyn, Nutt, David J, Peters, Tim J, Wiles, Nicola J, Lewis, Gemma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358567/
https://www.ncbi.nlm.nih.gov/pubmed/33637001
http://dx.doi.org/10.1177/0269881120986417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358567/
https://www.ncbi.nlm.nih.gov/pubmed/33637001
http://dx.doi.org/10.1177/0269881120986417

Ejemplares similares